Faculty, Staff and Student Publications
Language
English
Publication Date
11-1-2025
Journal
Advanced Science
DOI
10.1002/advs.202506294
PMID
40953331
PMCID
PMC12667481
PubMedCentral® Posted Date
9-15-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Radiotherapy is one of the most important adjuvant treatment methods for gastric cancer (GC). However, radioresistance remains a major clinical obstacle. In this study, APOL2 is identified as a key player in promoting non-homologous end joining (NHEJ)-mediated double-strand break (DSB) repair and enhancing radioresistance in GC. Bioinformatics and clinical data revealed that high APOL2 expression is correlated with poor prognosis in GC patients. Functional experiments showed that APOL2 overexpression enhances genomic stability by accelerating DSB repair via the NHEJ pathway, while APOL2 knockout impairs repair capacity. Mechanistically, APOL2 binds to and stabilizes Ku80 by enhancing USP7-mediated deubiquitylation, thereby increasing Ku80 protein levels to promote NHEJ repair, ultimately conferring radioresistance. Moreover, high-throughput screening identified formononetin (FN) as a small molecule capable of disrupting the APOL2-Ku80 interaction, thereby restoring radiosensitivity in GC cells. Our findings underscore the role of APOL2 in mediating radioresistance through Ku80 stabilization and highlight FN as a potential therapeutic agent to counteract radioresistance in GC treatment.
Keywords
Humans, Ku Autoantigen, Stomach Neoplasms, Radiation Tolerance, DNA End-Joining Repair, Cell Line, Tumor, Mice, Animals, DNA Breaks, Double-Stranded, APOL2, gastric cancer, Ku80, NHEJ, ubiquitination
Published Open-Access
yes
Recommended Citation
Zu, Dan; Bao, Qimei; He, Hanyi; et al., "APOL2 Stabilizes Ku80 to Confer NHEJ-Mediated Radioresistance in Gastric Cancer" (2025). Faculty, Staff and Student Publications. 6575.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6575
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons